Epizyme, Inc.
DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA

Abstract:

The present invention relates to DOT1L inhibitors. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.